ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 287459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 287459; 2) Community: the network communities that were significantly associated with the response to NSC 287459; 3) Molecule: the relationships between components within communities and NSC 287459; 4) MDR: the compounds that were significantly associated with the NSC 287459.

NSC Compound Enrichment Correlation
NSC 86354 (p-Nitrophenyl)phenyliodonium bromide 0.0152619242759636 0.21699918
NSC 680721 5H-1,4,8,11-Benzotetrathiacyclotridecin- 13,14-dicarbonitrile, 2,3,6,7,9,10-hexahydro- 0.017138169515949 -0.12306306
NSC 709928 Null 0.017138169515949 -0.28105563
NSC 736049 N-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N'-(2-met hylimidazo[1,2-a]pyridin-3-yl)urea 0.017138169515949 -0.17865024
NSC 81052 Streptonigrin analog (MeO-N3) 0.017138169515949 0.42413582
NSC 107124 Camptothecin Derivative 0.0179905510964914 0.59438922
NSC 109836 Null 0.0179905510964914 0.26554609
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0179905510964914 0.5631153
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0179905510964914 0.33636277
NSC 258812 N,N-Dimethyldaunomycin hydrochloride 0.0179905510964914 0.4615772
Total:93  Current:37    [First] [Prev] [Next] [Last]